AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Heidelberg Pharma AG

Share Issue/Capital Change Mar 23, 2010

201_rns_2010-03-23_eed1f0a3-1511-40f1-add9-7ef64807b717.html

Share Issue/Capital Change

Open in Viewer

Opens in native device viewer

News Details

Ad-hoc | 23 March 2010 08:01

WILEX AG secures financing up to EUR 20 million through an equity line

WILEX AG / Corporate Action

23.03.2010 08:01

Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.


Munich, 23 March 2010. WILEX AG (ISIN DE0006614720 / Frankfurt Stock
Exchange / Prime Standard) has entered into a three year Standby Equity
Distribution Agreement (SEDA) with YA Global Master SPV LTD (YA Global), a
fund managed by Yorkville Advisors, LLC both located in New Jersey, USA.

The SEDA entitles WILEX to issue new shares from authorised capital to be
sold in tranches of up to EUR 1 million to YA Global. Upon WILEX' absolute
discretion YA Global is obliged to subscribe for and to purchase such
shares. WILEX intends to propose approval of new authorised capital at the
Annual General Meeting on 21 May 2010. If approved, this would enable the
company to initiate drawing funds starting in June 2010 onwards.

The total value of this equity facility aggregates to up to EUR 20 million,
provided that in no event shall the total number of shares owned by YA
Global exceed 9.9% of WILEX' share capital at any one time. The agreement
is valid for a period of 36 months following contract signature.

Contact
WILEX AG
Katja Arnold (CIRO)
Corporate Communications
Grillparzerstr. 10
81675 Munich; Germany
Tel.: +49 (0)89-41 31 38-126
Fax: +49 (0)89-41 31 38-99
E-mail: [email protected]

This communication contains certain forward-looking statements, relating to
the Company's business, which can be identified by the use of
forward-looking terminology such as 'estimates', 'believes', 'expects',
'may', 'will' 'should' 'future', 'potential' or similar expressions or by
general discussion of strategy, plans or intentions of the Company. Such
forward-looking statements involve known and unknown risks, uncertainties
and other factors, which may cause our actual results of operations,
financial condition, performance, or achievements, or industry results, to
be materially different from any future results, performance or
achievements expressed or implied by such forward-looking statements. Given
these uncertainties, prospective investors and partners are cautioned not
to place undue reliance on such forward-looking statements. We disclaim any
obligation to update any such forward-looking statements to reflect future
events or developments. Given these uncertainties, prospective investors
and partners are cautioned not to place undue reliance on such
forward-looking statements. We disclaim any obligation to update any such
forward-looking statements to reflect future events or developments.

23.03.2010 Ad hoc announcement, Financial News and Media Release distributed by DGAP.
Media archive at www.dgap-medientreff.de and www.dgap.de


Language: English
Company: WILEX AG
Grillparzerstr. 10
81675 München
Deutschland
Phone: +49 (0)89 41 31 38 - 0
Fax: +49 (0)89 41 31 38 - 99
E-mail: [email protected]
Internet: www.wilex.com
ISIN: DE0006614720
WKN: 661472
Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr
in Berlin, Düsseldorf, München, Stuttgart

End of News DGAP News-Service


Talk to a Data Expert

Have a question? We'll get back to you promptly.